Luminal A breast cancer, Luminal B breast cancer, HER2-positive breast cancer, triple-negative breast cancer
Conditions
Interventions
Gold Standard:Immunohistochemistry (estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 proliferation index)
Index test:Radiomics Deep Learning Model
Sponsors
Gongli Hospital of Shanghai Pudong New Area
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.The patient is female. 2.Conventional ultrasound, UE and CEUS examinations were all performed before the operation; 3.Postoperative pathology confirmed it to be a malignant breast tumor, and there are complete clinical data; 4.No neoadjuvant chemotherapy or other treatments were received before the ultrasound examination;
Exclusion criteria
Exclusion criteria: 1.Received anti-cancer treatment before the ultrasound examination; 2.The postoperative pathology lacks complete immunohistochemical results; 3.The image quality is poor;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Receiver operating characteristic curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Area under the curve;Sensitivity;Negative predictive value;Specificity;Positive predictive value; | — |
Countries
China
Contacts
Public ContactXiaohong Fu
Gongli Hospital of Shanghai Pudong New Area
Outcome results
None listed